Intromedic Receives MFDS Approval for Human Body Communication-Based Capsule Endoscopy

[Asia Economy Reporter Hyunseok Yoo] Intromedic announced on the 10th that the Ministry of Food and Drug Safety (MFDS) approval for two types of upper gastrointestinal capsule endoscopes (MC2400-U, MC2400-UE), developed in March last year in collaboration with the Electronics and Telecommunications Research Institute (ETRI), has been completed.

The approved endoscopes utilize InBody human body communication technology to effectively diagnose the esophagus and stomach, which account for about 54% of human digestive diseases. InBody human body communication technology is a data transmission technology that uses a weak electric current flowing through the human body as a medium for information transfer, enabling high-speed data communication and allowing more information to be transmitted compared to existing products.

In the case of conventional wired endoscopes, there were factors that made examinations difficult, such as concerns about reuse, foreign body sensation, and abdominal bloating caused by air injection. Capsule endoscopes complement these shortcomings and are expected to become a means to replace wired endoscopes in the future.

An Intromedic official stated, “Due to the increase in infectious diseases and gastrointestinal disorders, the capsule endoscopy market is continuously growing,” and added, “We will continue to develop technology that can examine the entire digestive system, including the esophagus, stomach, and small intestine.” He also mentioned, “We are currently undergoing the European Union (EU) Conformit? Europ?enne (CE) certification process, and it is expected to be completed within this year.”